Proteasome inhibitors.
Reboud-Ravaux
Michèle
M
D000111:Acetylcysteine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D003374:Coumarins / Q000737:chemistry / Q000494:pharmacology; D003546:Cysteine Endopeptidases / Q000737:chemistry; D015853:Cysteine Proteinase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D006868:Hydrolysis; D007249:Inflammation / Q000188:drug therapy; D049934:Isocoumarins; D046911:Macromolecular Substances; D008970:Molecular Weight; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors* / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy; D010455:Peptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D046988:Proteasome Endopeptidase Complex; D013379:Substrate Specificity
D003374:Coumarins; D015853:Cysteine Proteinase Inhibitors; D049934:Isocoumarins; D046911:Macromolecular Substances; D009097:Multienzyme Complexes; D010455:Peptides; C067713:lactacystin; C046235:3,4-dichloroisocoumarin; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; D000111:Acetylcysteine